What are Zymeworks's total assets?

Zymeworks (ZYME) holds $478.2M in total assets, up 12.4% year over year.

How much debt does Zymeworks have?

Zymeworks carries $17.0M in total debt against $163.6M of shareholders' equity, a debt-to-equity ratio of 0.10.

How much cash does Zymeworks have?

Zymeworks holds $244.3M in cash and equivalents.

Can Zymeworks cover its short-term obligations?

Its current ratio is 10.82 — current assets exceed current liabilities.

Where does Zymeworks's balance sheet data come from?

Every line is extracted from Zymeworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Zymeworks ZYME Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$244.28M+494%	$41.16M-36.5%	$64.83M-34.0%	$98.25M+28.9%	$76.2M+15.3%
Accounts receivable, net	$4.67M+0.8%	$4.64M-84.2%	$29.35M+1,016%	$2.63M-89.3%	$24.59M-55.9%
Prepaid expenses and other current assets	$16.28M+6.2%	$15.33M+47.0%	$10.43M-14.0%	$12.12M-26.9%	$16.59M-12.1%
Trading assets	$120.45M-35.8%	$187.64M+0.3%	$187.1M+2.2%	$183.13M-3.2%	$189.08M+18.4%
Total current assets	$385.68M+55.0%	$248.77M-14.7%	$291.71M-1.5%	$296.13M-3.4%	$306.47M+2.0%
Property and equipment, net	$14.85M-4.2%	$15.5M-2.0%	$15.82M-3.0%	$16.31M-2.2%	$16.69M-5.5%
Operating lease right-of-use assets	$14.02M-10.9%	$15.72M-5.6%	$16.65M+2.4%	$16.26M-2.8%	$16.72M+0.3%
Goodwill	$12.02M0.0%	$12.02M0.0%	$12.02M0.0%	$12.02M0.0%	$12.02M0.0%
Intangible assets, net	$1.17M-13.0%	$1.35M-3.4%	$1.4M-31.7%	$2.05M-39.2%	$3.36M-26.5%
Deferred tax assets	$3.83M-36.5%	$6.03M+26.3%	$4.77M-1.6%	$4.85M+0.7%	$4.82M+1.1%
Long-term investments	$39.12M-6.4%	$41.79M-11.9%	$47.43M-8.8%	$52M-7.7%	$56.32M-42.8%
Available-for-sale securities	$159.47M-30.3%	$228.84M-2.2%	$233.92M-0.4%	$234.8M-4.2%	$245.15M-5.1%
Total assets	$478.22M+38.0%	$346.53M-12.8%	$397.27M-2.7%	$408.39M-4.0%	$425.52M-8.1%
Accounts payable	$30.23M-16.8%	$36.35M+2,685%	$1.31M+3,978%	$32K-99.4%	$5.22M+33.8%
Deferred revenue	$2.08M-14.1%	$2.42M-24.4%	$3.2M-16.1%	$3.81M-83.8%	$23.5M-8.2%
Operating lease liabilities, current	$3.28M-5.5%	$3.47M+2.1%	$3.4M-5.2%	$3.59M+10.1%	$3.26M+18.9%
Contract liabilities	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%
Income taxes payable	$66K-20.5%	$83K-91.8%	$1.02M+896%	$102K-19.7%	$127K-0.8%
Total current liabilities	$35.65M-15.8%	$42.32M+0.7%	$42.04M+9.2%	$38.5M-40.9%	$65.1M-26.3%
Operating lease liabilities, non-current	$13.76M-7.0%	$14.8M-4.6%	$15.5M+2.7%	$15.09M-0.5%	$15.17M-3.6%
Operating Lease Liabilities (Total)	$17.04M-6.7%	$18.27M-3.4%	$18.9M+1.2%	$18.68M+1.3%	$18.43M-0.2%
Other non-current liabilities	$278K0.0%	$278K0.0%	$278K-66.4%	$828K-3.3%	$856K-7.3%
Total liabilities	$314.63M+303%	$78.03M+1.1%	$77.21M+4.5%	$73.88M-26.5%	$100.56M-19.1%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	900M0.0%	900M0.0%	900M0.0%	900M0.0%	900M-11.4%
Additional paid-in capital	$107.53M-6.2%	$114.63M+2.8%	$111.49M+2.1%	$109.24M-29.2%	$154.22M+1.3%
Retained earnings	-$1.07B-12.7%	-$953.16M-7.5%	-$886.47M-4.2%	-$850.65M+0.3%	-$852.97M-2.7%
Accumulated other comprehensive income (loss)	-$6.57M-8.0%	-$6.08M-0.5%	-$6.05M+4.6%	-$6.34M+1.0%	-$6.41M+7.9%
Total stockholders' equity	$163.59M-39.1%	$268.5M-16.1%	$320.06M-4.3%	$334.51M+2.9%	$324.97M-4.1%
Total liabilities and stockholders' equity	$478.22M+38.0%	$346.53M-12.8%	$397.27M-2.7%	$408.39M-4.0%	$425.52M-8.1%
Available-for-Sale Debt Securities	$120.45M-35.8%	$187.64M+0.3%	$187.1M+2.2%	$183.13M-3.2%	$189.08M+18.4%
Available-for-Sale Debt Securities - Amortized Cost	$120.41M-35.8%	$187.46M+0.3%	$186.93M+2.1%	$183.07M-3.1%	$188.94M+18.3%
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)	$120.41M-35.8%	$187.46M+0.3%	$186.93M+2.1%	$183.07M-3.1%	$188.94M+18.3%
Debt securities - current	$120.45M-35.8%	$187.64M+0.3%	$187.1M+2.2%	$183.13M-3.2%	$189.08M+18.4%
Net Investment in Lease	$14.02M-10.9%	$15.72M-5.6%	$16.65M+2.4%	$16.26M-2.8%	$16.72M+0.3%
Deferred tax assets	$4.71M0.0%	$4.71M-3.2%	$4.86M+2.0%	$4.77M-1.6%	$4.85M+10.6%
Intangible assets — net	$1.17M-13.0%	$1.35M-3.4%	$1.4M-31.7%	$2.05M-39.2%	$3.36M-26.5%
Operating lease right-of-use assets	$14.02M-10.9%	$15.72M-5.6%	$16.65M+2.4%	$16.26M-2.8%	$16.72M+0.3%
Operating Lease Right-of-Use Assets in Other Assets	$14.02M-10.9%	$15.72M-5.6%	$16.65M+2.4%	$16.26M-2.8%	$16.72M+0.3%
Prepaid Expenses, Non-Current	$6.65M-0.3%	$6.67M-9.7%	$7.39M-16.6%	$8.86M-2.6%	$9.1M+2.0%
Accrued Progress Collections and Price Adjustments	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%
Accounts payable and other current liabilities (Note 11)	$30.23M-16.8%	$36.35M+5.6%	$34.43M+11.1%	$31M-18.9%	$38.22M-36.1%
Accrued Income Taxes, Current	$66K-20.5%	$83K-91.8%	$1.02M+896%	$102K-19.7%	$127K-0.8%
Lease Liability Payments - 2021	$4.2M—	——	$4.27M-2.2%	$4.36M+7.9%	$4.04M—
Lease Liability Payments - Due Year Two	$3.84M—	——	$4.13M+10.9%	$3.73M+1.8%	$3.66M—
Lease Liability Payments - Due Year Three	$3.61M—	——	$3.61M+13.1%	$3.2M-0.2%	$3.2M—
Lease Liability Payments - Due Year Four	$2.86M—	——	$3.34M+11.1%	$3M+1.5%	$2.96M—
Lease Liability Payments - Due Year Five	$2.66M—	——	$2.67M-2.2%	$2.73M+5.7%	$2.58M—
Operating Lease Liability Payments Due	$19.39M—	——	$21.57M+1.1%	$21.33M+0.7%	$21.18M—
Operating Lease Liability - Undiscounted Excess Amount	$2.35M—	——	$2.67M+0.5%	$2.66M-3.3%	$2.75M—
Contract Liabilities, Non-Current	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%
Lease Liability Payments - Due After Year Five	$2.22M—	——	$3.56M-17.7%	$4.32M-8.7%	$4.73M—
Deferred revenue, net of current portion	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%	$14.61M0.0%
Total debt	$17.04M-6.7%	$18.27M-3.4%	$18.9M+1.2%	$18.68M+1.1%	$18.47M-0.5%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	73.1M-2.1%	74.6M-0.7%	75.1M+0.4%	74.8M+7.6%	69.6M+0.9%
Convertible Preferred Stock Authorized Shares	100M0.0%	100M0.0%	100M0.0%	100M0.0%	100M0.0%
Convertible Preferred Stock Issued Shares	10.0%	10.0%	10.0%	10.0%	10.0%
Convertible Preferred Stock Outstanding Shares	10.0%	10.0%	10.0%	10.0%	10.0%
Additional paid-in capital	$107.53M-6.2%	$114.63M+2.8%	$111.49M+2.1%	$109.24M-29.2%	$154.22M+1.3%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$1.13B+2.1%	$1.11B+1.1%	$1.09B+1.8%	$1.07B+5.1%	$1.02B+0.6%
Exchangeable shares, no par value, 550,884 and 553,184 issued and outstanding shares at March 31, 2026 and December 31, 2025, respectively	$7.91M-0.4%	$7.94M-2.8%	$8.17M-0.1%	$8.18M0.0%	$8.18M-0.1%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Shares Reserved for Future Issuance Under Stock Plans	6M+18.8%	5M-10.8%	5.6M+2.8%	5.5M+2.9%	5.3M+2.5%
Liability related to sale of future royalties	$246.5M—	$0—	——	——	——
All classes of stock, shares authorized (in shares)	1B—	——	1B0.0%	1B0.0%	1B—
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One	$120.41M-35.8%	$187.46M+0.3%	$186.93M+2.1%	$183.07M-3.1%	$188.94M+18.3%
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	$120.45M-35.8%	$187.64M+0.3%	$187.1M+2.2%	$183.13M-3.2%	$189.08M+18.4%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$900M0.0%	$900M0.0%	$900M0.0%	$900M0.0%	$900M0.0%
Common stock, shares issued (in shares)	$73.1M-2.1%	$74.64M-0.7%	$75.14M+0.4%	$74.85M+7.6%	$69.58M+0.9%
Common Stock, Shares, Outstanding	$73.1M-2.1%	$74.64M-0.7%	$75.14M+0.4%	$74.85M+7.6%	$69.58M+0.9%
Contract with Customer, Asset, after Allowance for Credit Loss	$1.55M-43.5%	$2.75M+183%	$971K+70.7%	$569K+189%	$197K+97.0%
Debt Securities And Equity Securities Without Readily Determinable Fair Value	$39.12M-6.4%	$41.79M-11.9%	$47.43M-8.8%	$52M-7.7%	$56.32M-42.8%
Debt Securities And Equity Securities Without Readily Determinable Fair Value, Cost	$39.05M-5.6%	$41.39M-11.9%	$46.99M-9.2%	$51.73M-8.0%	$56.21M-43.1%
Cost or Amortized Cost	$159.47M-30.3%	$228.84M-2.2%	$233.92M-0.4%	$234.8M-4.2%	$245.15M-5.1%
Estimated Fair Value	$159.56M-30.5%	$229.43M-2.2%	$234.53M-0.3%	$235.12M-4.2%	$245.41M-4.9%
Deferred income taxes	$3.83M-36.5%	$6.03M+26.3%	$4.77M-1.6%	$4.85M+0.7%	$4.82M+1.1%
Exchangeable stock, shares issued (in shares)	550.9K-0.4%	553.2K-2.8%	569.2K-0.1%	569.9K0.0%	569.9K-0.1%
Exchangeable stock, shares outstanding (in shares)	550.9K-0.4%	553.2K-2.8%	569.2K-0.1%	569.9K0.0%	569.9K-0.1%
Lessee Operating Lease Liability Payments Due	$19.39M—	——	$21.57M+1.1%	$21.33M+0.7%	$21.18M—
Lessee Operating Lease Liability Undiscounted Excess Amount	$2.35M—	——	$2.67M+0.5%	$2.66M-3.3%	$2.75M—
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%
Preferred Stock, Shares Issued	$10.0%	$10.0%	$10.0%	$10.0%	$10.0%
Preferred Stock, Shares Outstanding	$10.0%	$10.0%	$10.0%	$10.0%	$10.0%
Incentive stock program, shares reserved for future grants (in shares)	$5.97M+18.8%	$5.02M-10.8%	$5.63M+2.8%	$5.48M+2.9%	$5.33M+2.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Zymeworks.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Zymeworks's total assets?: Zymeworks (ZYME) holds $478.2M in total assets, up 12.4% year over year.
How much debt does Zymeworks have?: Zymeworks carries $17.0M in total debt against $163.6M of shareholders' equity, a debt-to-equity ratio of 0.10.
How much cash does Zymeworks have?: Zymeworks holds $244.3M in cash and equivalents.
Can Zymeworks cover its short-term obligations?: Its current ratio is 10.82 — current assets exceed current liabilities.
Where does Zymeworks's balance sheet data come from?: Every line is extracted from Zymeworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.